What makes Genentech so special is its innovation cultureCompelling as it was, reacquisition of the company shows Roche’s management bandwidth & far sight, too.
March 19, 2009
Will affordable drugs remain a need unfulfilled?Making drugs affordable and accessible to the needy masses has been the stated intention of the UPA government from the time it came to power five years ago.
February 26, 2009
Clinical trials for multinationals ‘killing the poor in India’Close on heels of the controversy about an alleged clinical trial death on one of Wyeth’s paediatric vaccines, there is more damning revelation
February 19, 2009
Sanofi fits better with Piramal than GlaxoAfter Pfizer declared its plans to acquire Wyeth that will swell its topline to $70 billion, the most obvious question was when Pfizer’s peers will react to these moves.
February 9, 2009
Foreign drug majors’ latest gambit — restraining the Drug ControllerPatent-related rows between Indian and multinational drug companies are here to stay. If anything, the fight between the two lobbies will get fiercer by the day.
January 15, 2009
FCCBs prove a nagging headache for domestic pharma companiesWhat was perceived to be an easy option to raise funds through foreign currency convertible bonds (FCCBs) two to three years ago is turning out to be a nightmare for Indian drug makers.
January 9, 2009
Odds heavy against Wockhardt finding a way outAs we get acclimatised to the unprecedented global economic calamity, leading Indian drug companies are taking it on their chins. One such big name is Wockhardt.
December 25, 2008
Seismic shifts in pharma spell dooms for firmsSeismic shifts in pharmaceutical industry spells doom for firms both big and small.
December 18, 2008
Pharma Inc must come clear on clinical trialsPharma Inc must come clear on clinical trials, build confidence.
Recent reports of infant deaths due to faulty trials make a compelling case for this
December 11, 2008
European Commission exposé has pharma innovators in a bindSome of the dirtiest tricks of global drug giants to corner market share and maintain monopoly have been thrown in the open by a 426-page preliminary report of the European Commission.
December 4, 2008
Good traction in Indian pharmaceuticals researchIn a move that stunned many industry watchers, Pfizer announced its plans to withdraw from further research on heart drugs.
October 9, 2008
The only ‘consolidator’ in world generics has guns blazingTeva never fails to amaze. Barely a month after it struck a deal to own the US-based Barr Labs for nearly $8 billion, the company recently did one more unique collaboration
October 2, 2008
Did Ranbaxy deserve the blow BY US FDA?Pharma major may have erred in not taking timely remedial action.
September 25, 2008
|
ReportsOur columnists
Contributors
|
|
||||||